NCT01789762View on ClinicalTrials.gov

Evaluation of the Efficacy of Platelets Treated With Pathogen Reduction Process

PHASE4CompletedINTERVENTIONAL
Enrollment

842

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Aplasia With Expected Thrombocytopenia
Interventions
BIOLOGICAL

Autologous plasma

Transfusions of platelet concentrates re-suspended in autologous plasma

BIOLOGICAL

Additive solution

Transfusions of platelets prepared in additive solution (Intersol)

BIOLOGICAL

Pathogen reduction process

Patients transfused with platelets treated by pathogen reduction process

Trial Locations (12)

13273

Institut Paoli Calmette, Marseille

21000

CHU de Dijon, Dijon

25030

CHU de Besancon, Besançon

35033

CHU de Rennes, Rennes

38700

CHU de Grenoble, Grenoble

42271

Institut de Cancérologie de la Loire, Saint-Priest-en-Jarez

59037

Hopital Huriez - CHRU Lille, Lille

63003

CHU de Clermont Ferrand, Clermont-Ferrand

69495

Hospices Civils de Lyon - Lyon Sud, Pierre-Bénite

75012

Hopital Saint Antoine, Paris

94000

CHU Henri Mondor - APHP, Créteil

Unknown

CHU de Brest, Brest

All Listed Sponsors
collaborator

University Hospital, Grenoble

OTHER

lead

Etablissement Français du Sang

OTHER

NCT01789762 - Evaluation of the Efficacy of Platelets Treated With Pathogen Reduction Process | Biotech Hunter | Biotech Hunter